tiprankstipranks
Trending News
More News >
iX Biopharma Ltd. (SG:42C)
SGX:42C
Singapore Market

iX Biopharma Ltd. (42C) Financial Statements

Compare
11 Followers

iX Biopharma Ltd. Financial Overview

iX Biopharma Ltd.'s market cap is currently S$140.83M. The company's EPS TTM is S$-0.004; its P/E ratio is -12.50; iX Biopharma Ltd. is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is S$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueS$ 7.77MS$ 5.96MS$ 5.91MS$ 14.39MS$ 1.75M
Gross ProfitS$ 2.04MS$ 1.05MS$ 2.32MS$ 12.29MS$ -382.00K
Operating IncomeS$ -6.29MS$ -7.39MS$ -8.41MS$ 1.24MS$ -11.43M
EBITDAS$ -8.96MS$ -8.68MS$ -8.51MS$ -2.84MS$ -10.79M
Net IncomeS$ -10.14MS$ -10.79MS$ -9.62MS$ -4.60MS$ -8.23M
Balance Sheet
Cash & Short-Term InvestmentsS$ 866.00KS$ 1.77MS$ 6.52MS$ 13.49MS$ 6.21M
Total AssetsS$ 11.28MS$ 14.62MS$ 24.93MS$ 28.52MS$ 18.86M
Total DebtS$ 5.90MS$ 5.20MS$ 4.34MS$ 4.41MS$ 4.24M
Net DebtS$ 5.04MS$ 3.43MS$ -2.18MS$ -9.09MS$ -1.97M
Total LiabilitiesS$ 10.92MS$ 10.28MS$ 9.08MS$ 8.77MS$ 7.15M
Stockholders' EquityS$ 365.00KS$ 4.34MS$ 15.85MS$ 19.74MS$ 11.71M
Cash Flow
Free Cash FlowS$ -3.96MS$ -6.84MS$ -8.36MS$ 2.92MS$ -8.90M
Operating Cash FlowS$ -3.76MS$ -6.55MS$ -7.66MS$ 3.12MS$ -8.35M
Investing Cash FlowS$ -201.00KS$ 1.06MS$ -695.00KS$ -5.62MS$ -507.00K
Financing Cash FlowS$ 3.12MS$ 724.00KS$ 1.42MS$ 9.79MS$ 10.02M
Currency in SGD

iX Biopharma Ltd. Earnings and Revenue History

iX Biopharma Ltd. Debt to Assets

iX Biopharma Ltd. Cash Flow

iX Biopharma Ltd. Forecast EPS vs Actual EPS